Nanobiotix (NBTX) — Strategic Asset Allocation Index
Nanobiotix (NBTX) has a Strategic Asset Allocation Index of 433.3% as of June 2022. Strategic assets (PP&E of $7.41 Million plus long-term investments of $352.00K) total $7.76 Million, measured against net assets of $1.79 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check NBTX financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Nanobiotix Strategic Asset Allocation Index (2016–2021)
This chart shows how Nanobiotix's Strategic Asset Allocation Index has evolved across 5 annual periods from 2016 to 2021. As of June 2022, the index stands at 433.3%, representing strategic assets of $7.76 Million against net assets of $1.79 Million USD. See how financially flexible is Nanobiotix to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Nanobiotix (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Nanobiotix from 2016 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is Nanobiotix worth.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 30.9% | $8.28 Million | $8.19 Million | $98.00K | $26.79 Million | ▲ +19.1 pp |
| 2020 | 11.9% | $8.36 Million | $8.26 Million | $105.00K | $70.47 Million | ▼ -9.6 pp |
| 2018 | 21.5% | $3.06 Million | $2.88 Million | $176.00K | $14.24 Million | ▲ +14.7 pp |
| 2017 | 6.8% | $2.99 Million | $2.99 Million | $- | $43.92 Million | ▼ -7.2 pp |
| 2016 | 14.0% | $2.43 Million | $2.43 Million | $- | $17.40 Million | — |